Swiss National Bank
MDCO

Swiss National Bank’s Medicines Co MDCO Stock Holding History

Swiss National Bank’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-151,950
Closed -$12.9M – 2507
2019
Q4 		$12.9M Buy
151,950
+13,100
+9% +$874K 0.01% 684
2019
Q3 		$6.94M Buy
138,850
+1,500
+1% +$59.8K 0.01% 919
2019
Q2 		$5.01M Buy
137,350
+2,700
+2% +$88.1K 0.01% 1121
2019
Q1 		$3.76M Buy
134,650
+4,200
+3% +$99K ﹤0.01% 1264
2018
Q4 		$2.5M Buy
130,450
+2,100
+2% +$48.9K ﹤0.01% 1426
2018
Q3 		$3.84M Buy
128,350
+1,800
+1% +$67.8K ﹤0.01% 1290
2018
Q2 		$4.64M Hold
126,550
– – 0.01% 1156
2018
Q1 		$4.17M Buy
126,550
+2,900
+2% +$90.6K 0.01% 1153
2017
Q4 		$3.38M Buy
123,650
+3,000
+2% +$92.4K ﹤0.01% 1307
2017
Q3 		$4.47M Buy
120,650
+1,900
+2% +$70K 0.01% 1095
2017
Q2 		$4.51M Buy
118,750
+2,100
+2% +$93.5K 0.01% 1060
2017
Q1 		$5.7M Buy
116,650
+700
+0.6% +$31.9K 0.01% 914
2016
Q4 		$3.94M Buy
115,950
+3,900
+3% +$138K 0.01% 1112
2016
Q3 		$4.23M Sell
112,050
-3,600
-3% -$136K 0.01% 1012
2016
Q2 		$3.89M Hold
115,650
– – 0.01% 1049
2016
Q1 		$3.55M Buy
115,650
+26,750
+30% +$874K 0.01% 1077
2015
Q4 		$3.32M Hold
88,900
– – 0.01% 1011
2015
Q3 		$3.38M Buy
88,900
+11,800
+15% +$414K 0.01% 993
2015
Q2 		$2.21M Buy
77,100
+6,500
+9% +$181K 0.01% 1248
2015
Q1 		$1.98M Buy
70,600
+1,000
+1% +$28.1K 0.01% 1292
2014
Q4 		$1.93M Buy
69,600
+1,800
+3% +$44.6K 0.01% 1281
2014
Q3 		$1.51M Sell
67,800
-800
-1% -$20.3K 0.01% 1390
2014
Q2 		$1.99M Hold
68,600
– – 0.01% 1259
2014
Q1 		$1.95M Buy
68,600
+17,100
+33% +$566K 0.01% 1227
2013
Q4 		$1.99M Hold
51,500
– – 0.01% 1066
2013
Q3 		$1.73M Buy
51,500
+2,600
+5% +$82.8K 0.01% 1097
2013
Q2 		$1.5M Buy
+48,900
New +$1.64M 0.01% 1160

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Swiss National Bank's MDCO Position: Q1 2020 in Review

Swiss National Bank sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 151,950 shares — an estimated $12.9M sold.

Swiss National Bank first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $12.9M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Swiss National Bank reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Swiss National Bank sold 151,950 Medicines Co shares in Q1 2020, an estimated $12.9M.
  • Swiss National Bank first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
  • Swiss National Bank's Medicines Co position peaked at $12.9M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Swiss National Bank's 13F filing for Q1 2020, filed 8 May 2020.